Showing results (111-120 of 969) with videos related to
Sort By:
Pageof 97
Hematology. American Society of Hematology. Education Program|December 9, 2023
Novel immunotherapies in the treatment of AML: is there hope?Marion Subklewe, Veit Bücklein, David Sallman, et al.Seminars in Hematology|October 19, 2024
Therapy-related myelodysplastic syndromes and acute myeloid leukemiaSangeetha Venugopal, Amy E DeZernJAMA Oncology|August 8, 2024
Contemporary Management of Acute Myeloid Leukemia: A ReviewSangeetha Venugopal, Mikkael A SekeresLeukemia & Lymphoma|April 8, 2023
Raising the bar for lower-risk myelodysplastic syndromesSangeetha Venugopal, Mikkael A SekeresClinical Lymphoma, Myeloma & Leukemia|October 4, 2021
SOHO State of the Art Updates and Next Questions:Harnessing Apoptosis in AMLKapil Saxena, Courtney DiNardo, Naval Daver, et al.Cancer|October 23, 2025
A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lensHagop M Kantarjian, Gautam Borthakur, Naval Daver, et al.Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Harnessing Apoptosis in AMLKapil Saxena, Courtney DiNardo, Naval Daver, et al.Expert Review of Hematology|August 12, 2017
Immunotherapy based approaches in myelofibrosisLucia Masarova, Srdan Verstovsek, Hagop Kantarjian, et al.American Journal of Hematology|October 14, 2017
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitorsAhmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, et al.Leukemia & Lymphoma|September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapsePreetesh Jain, Hagop Kantarjian, Keyur Patel, et al.Pageof 97